Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma Of Esophagus × obinutuzumab × 90 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 22 Lymphoma, Non-Hodgkin 10 Lymphoma, Follicular 8 Lymphoma 7 Lymphoma, Mantle-Cell 6 Lymphoma, Large B-Cell, Diffuse 5 Recurrence 4 Neoplasms 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma, B-Cell 3 Leukemia, Hairy Cell 2 Leukemia 2 Burkitt Lymphoma 2 Neoplasm, Residual 1 Lymphatic Diseases 1 Leukemia, B-Cell 1 Heart Failure 1 Extensive Stage Small Cell Lung Cancer 1 Dendritic Cell Sarcoma, Interdigitating 1 Cytokine Release Syndrome 1

Interventions

Fluorouracil 10 Oxaliplatin 9 Nivolumab 9 Leucovorin 8 Capecitabine 7 pembrolizumab 4 Trastuzumab 4 Paclitaxel 4 Cisplatin 4 Specimen Handling 3 Irinotecan 3 Docetaxel 3 zimberelimab 2 zanidatamab 2 durvalumab 2 dehydroftorafur 2 Taxes 2 Radiotherapy 2 Radiation 2 Magnetic Resonance Spectroscopy 2 Endoscopy 2 Drug Therapy 2 Carboplatin 2 Biopsy 2 zolbetuximab 1 tucatinib 1 trifluridine tipiracil drug combination 1 tremelimumab 1 trastuzumab deruxtecan 1 trastuzumab biosimilar HLX02 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡